World News: 16:44 GMT Friday 2nd August 2019. [AB Science via Globe Newswire via SPi World News]
The phase 3 trial AB08026 was an open-label controlled study comparingto dacarbazine and designed to assess the and efficacy of masitinib 75 mgkgday in with non-resectable or metastatic stage 3 or stage 4 melanoma ca rrying ...
Globe Newswire: 16:44 GMT Friday 2nd August 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.